Saturday, October 3, 2026
21.3 C
Bengaluru

Going Digital – What Indian Pharma C-Suite has to Say

Any transformational initiative must be driven by the CEO and the leadership team.

The current efforts by Indian Pharma companies to adopt digital, leaves much to be desired. They are tactical in nature, a knee jerk response to address the challenges brought in Covid19 that made large field force to sit at home - something they have never done before.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

spot_img

Related Articles

spot_imgspot_img